Most cited article(s)

You have access
Glucuronidation of Amine Substrates by Purified and Expressed UDP-Glucuronosyltransferase Proteins
Mitchell D. Green and Thomas R. Tephly

Drug Metabolism and Disposition September 1998, 26 (9) 860-867;
You have access
Inhibition of Cytochrome P-450 3A (CYP3A) in Human Intestinal and Liver Microsomes: Comparison of K _i Values and Impact of CYP3A5 Expression
Megan A. Gibbs, Kenneth E. Thummel, Danny D. Shen and Kent L. Kunze

Drug Metabolism and Disposition February 1999, 27 (2) 180-187;
You have access
COMPARISON OF INHIBITORY EFFECTS OF THE PROTON PUMP-INHIBITING DRUGS OMEPRAZOLE, ESOMEPRAZOLE, LANSOPRAZOLE, PANTOPRAZOLE, AND RABEPRAZOLE ON HUMAN CYTOCHROME P450 ACTIVITIES
Xue-Qing Li, Tommy B. Andersson, Marie Ahlström and Lars Weidolf

Drug Metabolism and Disposition August 2004, 32 (8) 821-827; DOI: https://doi.org/10.1124/dmd.32.8.821
You have access
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Thomas Walle, Faye Hsieh, Mark H. DeLegge, John E. Oatis and U. Kristina Walle

Drug Metabolism and Disposition December 2004, 32 (12) 1377-1382; DOI: https://doi.org/10.1124/dmd.104.000885
You have access
Prediction of Drug Clearance by Glucuronidation from in Vitro Data: Use of Combined Cytochrome P450 and UDP-Glucuronosyltransferase Cofactors in Alamethicin-Activated Human Liver Microsomes
Peter J. Kilford, Rowan Stringer, Bindi Sohal, J. Brian Houston and Aleksandra Galetin

Drug Metabolism and Disposition January 2009, 37 (1) 82-89; DOI: https://doi.org/10.1124/dmd.108.023853
You have access
Atypical Kinetic Profiles in Drug Metabolism Reactions
J. Matthew Hutzler and Timothy S. Tracy

Drug Metabolism and Disposition April 2002, 30 (4) 355-362; DOI: https://doi.org/10.1124/dmd.30.4.355
You have access
Expression of UGT1A and UGT2B mRNA in Human Normal Tissues and Various Cell Lines
Akiko Nakamura, Miki Nakajima, Hiroyuki Yamanaka, Ryoichi Fujiwara and Tsuyoshi Yokoi

Drug Metabolism and Disposition August 2008, 36 (8) 1461-1464; DOI: https://doi.org/10.1124/dmd.108.021428
You have access
Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.
L Pichard, I Fabre, G Fabre, J Domergue, B Saint Aubert, G Mourad and P Maurel

Drug Metabolism and Disposition September 1990, 18 (5) 595-606;
You have access
Comparison of Different Algorithms for Predicting Clinical Drug-Drug Interactions, Based on the Use of CYP3A4 in Vitro Data: Predictions of Compounds as Precipitants of Interaction
Odette A. Fahmi, Susan Hurst, David Plowchalk, Jack Cook, Feng Guo, Kuresh Youdim, Maurice Dickins, Alex Phipps, Amanda Darekar, Ruth Hyland and R. Scott Obach

Drug Metabolism and Disposition August 2009, 37 (8) 1658-1666; DOI: https://doi.org/10.1124/dmd.108.026252
You have access
The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America
Scott W. Grimm, Heidi J. Einolf, Steven D. Hall, Kan He, Heng-Keang Lim, Kah-Hiing John Ling, Chuang Lu, Amin A. Nomeir, Eleanore Seibert, Konstantine W. Skordos, George R. Tonn, Robert Van Horn, Regina W. Wang, Y. Nancy Wong, Tian J. Yang and R. Scott Obach

Drug Metabolism and Disposition July 2009, 37 (7) 1355-1370; DOI: https://doi.org/10.1124/dmd.109.026716

Main menu

User menu

Search

Most cited article(s)

Pages

Navigate

More Information

ASPET's Other Journals